We are live on ! Find out more
PHIOW

Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW

Delisted

PHIOW was delisted on the 21st of December, 2021.

Back to rankings

5 hedge funds and large institutions have $78K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$8.66K
2
SM
Sabby Management
Florida
+$7.78K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.3K
4
UBS Group
UBS Group
Switzerland
+$135
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$120

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$72K +$8.66K +217,023 New
SM
2
Sabby Management
Florida
$5K +$7.78K +194,959 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1K +$1.3K +32,663 New
LTFS
4
Ladenburg Thalmann Financial Services
Florida
– +$120 +3,000 New
UBS Group
5
UBS Group
Switzerland
– +$135 +3,378 New

PHIOW Hedge Fund Activity: Q4 2018 in Review

5 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q4 2018, worth a combined $78K.

Buyers outnumbered sellers: 5 funds opened new PHIOW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $8.66K.

  • 5 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $78K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q4 2018.
  • 5 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q4 2018 and 0 closed out, a net change of +5 holders.
  • The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q4 2018 was Anson Funds Management, an estimated $8.66K added.

Based on aggregated 13F filings for Q4 2018.